Beth Boyer

FDA should take a more active role in updating drug labels — when there’s strong evidence Every year, promising new uses for generic drugs emerge from academia, non-profits, and patient groups — yet most never reach patients. Not because ...

Generic #drugrepurposing offers a promising tool for drug development - but a system built for pharma will never realize this potential. In our new guest commentary, we argue #FDA can take actions to fix this. www.biocentury.com/article/657654

Regulatory Opportunities to Advance Generic Drug Repurposing

📣JUST PUBLISHED: Our white paper on regulatory opportunities to advance generic drug repurposing is now available online! This paper explores the role of the regulator and policy actions it can take to support repurposing initiatives. @dukemargolis.bsky.social
healthpolicy.duke.edu/publications...

Why can't I get over this feeling that I'm cheating when I use ChatGPT to help me write something? I know most people use it, but I have this stubbornness that tells me I'm a capable writer and shouldn't be taking short cuts. How do I get past this!? 😩

Measles and tariffs, what century is this?

It turns out it’s always veep and never house of cards

A brief timeline of the Signal group chat story so far

Trump Administration Live Updates: USAID Could Be Shut Down, Musk Says

USAID under threat: www.nytimes.com/live/2025/02...

NIH issues a policy to widen access to medical products that emerge from government-funded research NIH policy asks companies seeking licenses to sell medical products invented with government research to submit plans for ensuring greater access to patients.

NIH issues a policy to widen access to medical products that emerge from government-funded research www.statnews.com/pharmalot/20... via @statnews.com

House Republicans abandon PBM reform in push to keep government open Lawmakers are aiming to pass a government funding bill with extensions for public health programs and telehealth flexibilities.

"The removal is a major win for the PBMs and the health insurers that own them."

And yet, leaders are confused about why Americans are embracing vigilantism...

www.statnews.com/2024/12/19/r...

Unlocking The Full Potential Of Generic Drugs For Patients | Health Affairs Forefront Generic drug repurposing is an underused but promising tool for finding new, affordable therapies. Creating a pull incentive can spur developers to finally explore the untapped potential in these drug...

📣New Publication!📣
Check out our proposed solution to help unlock the full potential of generic drugs to meet patient needs. @dukemargolis.bsky.social www.healthaffairs.org/content/fore...